Bard Logo

2014 Press Releases

Webcast ImageWebcast
Q3 2014 C. R. Bard, Inc. Earnings Conference Call (Live)
10/22/14 at 5:00 p.m. ET
Q3 2014 C. R. Bard, Inc. Earnings Conference Call
Wednesday, October 22, 2014 5:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
E-mail Alerts Receive E-mail Alerts | RSS RSS Feeds
Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
DateTitle 
10/10/14The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 10, 2014-- C. R. Bard, Inc. (NYSE: BCR) today announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix® 035 Drug Coated Balloon (DCB) Catheter for percutaneous transluminal angioplasty (PTA), after pre-dilatation, for the treatment of de novo or restenotic lesions up to 150mm in length in native vascular disease of the superficial femoral or popliteal arteries with reference vessel diameters o... 
Printer Friendly Version
10/08/14Bard Declares Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 8, 2014-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 22 cents per share on Bard's common stock. The current indicated annual dividend rate is 88 cents per share. The dividend is payable on October 31, 2014 to shareholders of record at the close of business on October 20, 2014. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, N... 
Printer Friendly Version
10/01/14Bard to Host Earnings Conference Call on October 22, 2014
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 1, 2014-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Wednesday, October 22, 2014 at 5:00 PM EDT, to discuss the company’s third quarter 2014 operating results, and to provide financial guidance for the fourth quarter of 2014. Bard is scheduled to issue an earnings press release after the market closes on October 22, 2014. A live audio webcast of Bard's investo... 
Printer Friendly Version
07/24/14Bard Announces Second Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jul. 24, 2014-- C. R. Bard, Inc. (NYSE:BCR) today reported 2014 second quarter financial results. Second quarter 2014 net sales were $827.1 million, an increase of 9 percent over the prior-year period on a reported basis. Excluding the impact of foreign exchange, second quarter 2014 net sales increased 8 percent over the prior-year period. For the second quarter 2014, net sales in the U.S. were $555.1 million, ... 
Printer Friendly Version
07/01/14Bard to Host Earnings Conference Call on July 24, 2014
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jul. 1, 2014-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will host a conference call on Thursday, July 24, 2014 at 5:00 PM EDT, to discuss the company’s second quarter 2014 operating results, and to provide financial guidance for the third quarter of 2014. Bard is scheduled to issue an earnings press release after the market closes on July 24, 2014. A live audio webcast of Bard's investor conference ... 
Printer Friendly Version
06/12/14Circulatory System Devices Advisory Panel Provides a Unanimous Favorable Recommendation to FDA for the Lutonix® Drug Coated Balloon
Lutonix® DCB one step closer to becoming the first FDA-approved drug coated balloon for the treatment of patients with femoropopliteal occlusive disease MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 12, 2014-- C. R. Bard, Inc. (NYSE:BCR) today announced that the U.S. Food and Drug Administration’s (FDA) Circulatory System Devices Advisory Panel provided a unanimous favorable recommendation to FDA for use of the Lutonix® Drug Coated Balloon ... 
Printer Friendly Version
06/11/14Bard Announces $500 Million Share Repurchase Authorization
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 11, 2014-- The Board of Directors of C. R. Bard, Inc. (NYSE: BCR) today authorized the repurchase of up to $500 million of the company’s common stock. This is in addition to approximately $30 million remaining under the prior authorization announced in January 2014. Share repurchases will be made from time-to-time in the open market or through privately negotiated transactions. C. R. Bard, Inc. (www... 
Printer Friendly Version
06/11/14Bard Increases Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 11, 2014-- The Board of Directors of C. R. Bard, Inc. (NYSE: BCR) today increased the quarterly dividend on Bard's common stock by 5 percent, to 22 cents per share. The dividend is payable on August 1, 2014 to shareholders of record at the close of business on July 21, 2014. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer and ... 
Printer Friendly Version
05/02/14Bard to Host Investor Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--May 2, 2014-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will hold an investor conference on Monday, June 2, 2014 at 4:30 PM EDT in New York City. The conference will be hosted by Timothy M. Ring, chairman and chief executive officer, and will include an update on Bard's product pipeline. A live audio webcast of Bard's investor conference will be accessible to all investors through Bard’s websi... 
Printer Friendly Version
04/30/14Bard to Present at the Bank of America Merrill Lynch Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 30, 2014-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas, Nevada on May 14, 2014. Christopher S. Holland, senior vice president and chief financial officer, will discuss the company in a presentation scheduled to begin at 8:00 AM Pacific Daylight Time. A live webcast of Bard's presentation and question and answer ses... 
Printer Friendly Version
04/23/14Bard to Present at the Deutsche Bank Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 23, 2014-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Deutsche Bank Healthcare Conference in Boston, Massachusetts on May 7, 2014. Timothy M. Ring, chairman and chief executive officer, will discuss the company in a presentation scheduled to begin at 1:30 PM Eastern Daylight Time. A live webcast of Bard's presentation and question and answer session will be accessible t... 
Printer Friendly Version
04/22/14Bard Announces First Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 22, 2014-- C. R. Bard, Inc. (NYSE: BCR) today reported 2014 first quarter financial results. First quarter 2014 net sales were $799.3 million, an increase of 8 percent over the prior-year period on both an as-reported and constant currency basis. For the first quarter 2014, net sales in the U.S. were $551.4 million, an increase of 11 percent over the prior-year period. Net sales outside the U.S. wer... 
Printer Friendly Version
04/16/14Bard Declares Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 16, 2014-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 21 cents per share on Bard's common stock. The current indicated annual dividend rate is 84 cents per share. The dividend is payable on May 9, 2014 to shareholders of record at the close of business on April 28, 2014. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, N.J., i... 
Printer Friendly Version
04/01/14Bard to Host Earnings Conference Call on April 22, 2014
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 1, 2014-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Tuesday, April 22, 2014 at 5:00 PM EDT, to discuss the company’s first quarter 2014 operating results, and to provide financial guidance for the second quarter of 2014. Bard is scheduled to issue an earnings press release after the market closes on April 22, 2014. A live audio webcast of Bard's investor conf... 
Printer Friendly Version
03/25/14Bard to Present at the Needham Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Mar. 25, 2014-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Needham Healthcare Conference in New York City on April 8, 2014. Timothy M. Ring, chairman and chief executive officer, will discuss the company in a presentation scheduled to begin at 8:00 AM Eastern Daylight Time. A live webcast of Bard's presentation and question and answer session will be accessible to all investors thr... 
Printer Friendly Version
02/18/14Bard to Present at the Raymond James Institutional Investor Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Feb. 18, 2014-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the Raymond James Institutional Investor Conference in Orlando, Florida on March 4, 2014. Timothy M. Ring, chairman and chief executive officer, will discuss the company in a presentation scheduled to begin at 11:00 AM Eastern Standard Time. A live webcast of Bard's presentation and question and answer session will be acc... 
Printer Friendly Version
02/10/14Bard to Present at Citi 2014 Global Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Feb. 10, 2014-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the Citi 2014 Global Healthcare Conference in New York City on February 24, 2014. Timothy M. Ring, chairman and chief executive officer, will discuss the company in a presentation scheduled to begin at 9:40 AM Eastern Standard Time. A live webcast of Bard's presentation and question and answer session will be accessible t... 
Printer Friendly Version
01/30/14Bard Announces $500 Million Share Repurchase Authorization
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 30, 2014-- C. R. Bard, Inc. (NYSE:BCR) today announced that its Board of Directors has authorized the repurchase of up to $500 million of the company’s common stock. This new authorization is in addition to the approximately $55 million remaining under the Company’s prior authorization. Share repurchases will be made from time-to-time in the open market or through privately negotiated transactions. ... 
Printer Friendly Version
01/30/14Bard Announces Fourth Quarter Results
Diluted EPS of $8.28, $1.42 on Adjusted Basis MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 30, 2014-- C. R. Bard, Inc. (NYSE: BCR) today reported 2013 fourth quarter financial results. Fourth quarter 2013 net sales were $791.3 million, an increase of 4 percent over the prior-year period on both an as-reported basis and constant currency basis. For the fourth quarter 2013, net sales in the U.S. were $517.7 million and net sales outside the ... 
Printer Friendly Version
01/06/14Bard to Host Earnings Conference Call on January 30, 2014
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 6, 2014-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Thursday, January 30, 2014 at 5:00 PM EST, to discuss the company’s operating results for the fourth quarter and full year 2013, and to provide financial guidance for 2014. Bard is scheduled to issue an earnings press release after the market closes on January 30, 2014. A live audio webcast of Bard's investo... 
Printer Friendly Version